Pedro Sanchez de Lozada, Canid CEO
June 3, 2025 08:00 AM EDT
Financing
Startups
Health Tech

Canid rais­es $10M to man­age vac­cines for pe­di­a­tri­cians

Shelby Livingston

Health tech correspondent

Pro­vid­ing vac­cines to kids can be a ma­jor un­der­tak­ing for a pe­di­a­tri­cian’s of­fice.

Stock­ing up on the shots can be ex­pen­sive. Plus, there are the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

H1 buys Gen­er­al Cat­a­lyst-backed Rib­bon Health

Anne Wo­j­ci­c­ki and Re­gen­eron set to duke it out in restart­ed 23andMe auc­tion

FDA's Prasad ex­plains ra­tio­nale be­hind paus­ing Val­neva's chikun­gun­ya vac­cine in se­niors

Ex­clu­sive: Tech VC Am­pli­fy rais­es $200M for first biotech fund, hires El­liot Her­sh­berg as new part­ner

Strug­gling biotechs suc­cumb to icy mar­ket, as mon­ey dries up and clin­i­cal bets don’t pay off

sponsored

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

A service from the Financial Times